Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2310046K 01Rik |  |
NM_027172 |
RIKEN cDNA 2310046K01 gene (2310046K01Rik), mRNA [NM_027172] |
KLA | .89 |
.89 |
.89 |
.85 |
.85 |
.95 |
1.04 |
| ATP | .96 |
.99 |
.94 |
.83 |
.75 |
.91 |
.89 |
| KLA/ATP | .87 |
.86 |
.88 |
.82 |
.79 |
.82 |
.91 |
|
Abcc1 |  |
NM_008576 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 (Abcc1), mRNA [NM_008576] |
KLA | 1.13 |
1.15 |
.99 |
.80 |
.68 |
.47 |
.78 |
| ATP | .99 |
1.05 |
1.05 |
.89 |
1.40 |
1.96 |
1.02 |
| KLA/ATP | 1.17 |
1.22 |
1.01 |
.78 |
.64 |
.80 |
1.07 |
|
Apoa1 |  |
NM_009692 |
apolipoprotein A-I (Apoa1), mRNA [NM_009692] |
KLA | .99 |
1.00 |
1.00 |
1.02 |
1.01 |
1.02 |
.98 |
| ATP | 1.00 |
1.00 |
1.02 |
1.16 |
1.03 |
1.04 |
1.01 |
| KLA/ATP | 1.00 |
1.03 |
1.07 |
1.23 |
1.10 |
1.05 |
.98 |
|
Apoa4 |  |
NM_007468 |
apolipoprotein A-IV (Apoa4), mRNA [NM_007468] |
KLA | .95 |
.99 |
.93 |
.99 |
1.03 |
.99 |
1.02 |
| ATP | .98 |
1.07 |
.99 |
1.00 |
.99 |
1.04 |
1.01 |
| KLA/ATP | 1.00 |
.91 |
.93 |
1.01 |
1.02 |
1.01 |
1.03 |
|
Apob |  |
NM_009693 |
apolipoprotein B (Apob), mRNA [NM_009693] |
KLA | 1.02 |
.97 |
.99 |
.99 |
1.00 |
1.01 |
.99 |
| ATP | .98 |
.96 |
1.05 |
1.06 |
1.04 |
.99 |
1.06 |
| KLA/ATP | .98 |
1.07 |
.97 |
1.01 |
.98 |
1.05 |
1.00 |
|
Btd |  |
NM_025295 |
biotinidase (Btd), mRNA [NM_025295] |
KLA | .89 |
.88 |
.87 |
.74 |
.90 |
1.07 |
1.06 |
| ATP | .97 |
1.05 |
1.26 |
1.39 |
1.39 |
2.45 |
2.08 |
| KLA/ATP | .86 |
.89 |
1.01 |
1.14 |
1.11 |
1.74 |
2.61 |
|
Cubn |  |
NM_001081084 |
cubilin (intrinsic factor-cobalamin receptor) (Cubn), mRNA [NM_001081084] |
KLA | 1.14 |
1.08 |
1.08 |
1.02 |
1.23 |
1.02 |
.97 |
| ATP | 1.03 |
.93 |
1.02 |
1.37 |
1.85 |
1.36 |
1.08 |
| KLA/ATP | 1.09 |
1.08 |
1.12 |
1.22 |
1.46 |
1.03 |
1.10 |
|
Dgat2l4 |  |
NM_177746 |
diacylglycerol O-acyltransferase 2-like 4 (Dgat2l4), mRNA [NM_177746] |
KLA | 1.12 |
1.13 |
1.13 |
1.07 |
1.12 |
1.02 |
.98 |
| ATP | 1.01 |
1.01 |
1.04 |
1.08 |
.93 |
.93 |
.93 |
| KLA/ATP | 1.16 |
1.15 |
1.09 |
1.04 |
.99 |
1.00 |
1.02 |
|
Folh1 |  |
NM_016770 |
folate hydrolase (Folh1), mRNA [NM_016770] |
KLA | 1.04 |
1.04 |
.99 |
1.06 |
1.03 |
1.00 |
1.02 |
| ATP | 1.08 |
.96 |
.93 |
1.00 |
1.05 |
.98 |
.99 |
| KLA/ATP | 1.02 |
.99 |
1.21 |
.98 |
1.00 |
1.02 |
.97 |
|
Gif |  |
NM_008118 |
gastric intrinsic factor (Gif), mRNA [NM_008118] |
KLA | 1.03 |
1.01 |
.98 |
1.00 |
1.02 |
1.00 |
1.03 |
| ATP | .99 |
.97 |
1.03 |
1.06 |
1.02 |
1.00 |
.99 |
| KLA/ATP | 1.03 |
1.02 |
.84 |
1.04 |
1.02 |
1.05 |
1.03 |
|
Lmbrd1 |  |
NM_026719 |
LMBR1 domain containing 1 (Lmbrd1), mRNA [NM_026719] |
KLA | 1.15 |
1.16 |
1.09 |
1.02 |
1.16 |
1.22 |
1.42 |
| ATP | 1.09 |
1.22 |
1.12 |
1.49 |
1.50 |
1.28 |
1.23 |
| KLA/ATP | 1.21 |
1.18 |
1.06 |
1.44 |
1.32 |
1.45 |
1.32 |
|
Lrat |  |
NM_023624 |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) (Lrat), mRNA [NM_023624] |
KLA | 1.01 |
.98 |
1.00 |
1.00 |
.96 |
1.01 |
1.00 |
| ATP | .97 |
1.05 |
1.04 |
1.04 |
1.00 |
1.06 |
1.01 |
| KLA/ATP | .99 |
1.04 |
1.00 |
1.01 |
1.06 |
1.00 |
1.00 |
|
Mm.16006 7 |  |
124487226 |
Unknown |
KLA | .90 |
.88 |
.87 |
.85 |
.80 |
.85 |
.64 |
| ATP | .95 |
.95 |
1.00 |
.94 |
1.00 |
.91 |
.67 |
| KLA/ATP | .89 |
.86 |
.93 |
.82 |
.85 |
.84 |
.63 |
|
Mm.26913 7 |  |
31980799 |
Unknown |
KLA | 1.04 |
1.07 |
1.01 |
1.02 |
1.00 |
1.03 |
.93 |
| ATP | 1.04 |
.96 |
1.00 |
.98 |
.98 |
.97 |
1.06 |
| KLA/ATP | 1.06 |
.95 |
.98 |
1.08 |
.99 |
.93 |
.91 |
|
Mmachc |  |
NM_025962 |
methylmalonic aciduria cblC type, with homocystinuria (Mmachc), mRNA [NM_025962] |
KLA | .90 |
.87 |
.80 |
.90 |
.61 |
.59 |
.89 |
| ATP | .89 |
.88 |
1.29 |
1.06 |
.59 |
.45 |
.87 |
| KLA/ATP | .79 |
.95 |
1.05 |
.86 |
.75 |
.39 |
.38 |
|
Plb1 |  |
AK015993 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993] |
KLA | .99 |
.99 |
1.05 |
1.02 |
1.03 |
1.07 |
1.02 |
| ATP | 1.04 |
1.03 |
1.07 |
1.06 |
1.09 |
1.01 |
1.02 |
| KLA/ATP | 1.07 |
1.00 |
.96 |
1.09 |
1.05 |
1.08 |
1.01 |
|
Plb1 |  |
AK087596 |
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596] |
KLA | .93 |
.99 |
.99 |
1.07 |
.98 |
1.00 |
.98 |
| ATP | 1.08 |
1.00 |
.97 |
1.07 |
1.04 |
1.09 |
.96 |
| KLA/ATP | 1.06 |
.96 |
1.00 |
.98 |
1.04 |
1.06 |
.98 |
|
Plb1 |  |
NM_001081407 |
phospholipase B1 (Plb1), mRNA [NM_001081407] |
KLA | 1.05 |
1.09 |
1.05 |
1.04 |
1.05 |
1.03 |
.85 |
| ATP | .96 |
1.03 |
1.02 |
.95 |
1.06 |
1.01 |
.92 |
| KLA/ATP | 1.00 |
1.00 |
1.09 |
1.00 |
.97 |
.99 |
.86 |
|
Pnlip |  |
AK007357 |
10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810007A24 product:PANCREATIC TRIGLYCERIDE LIPASE (FRAGMENT) homolog [Rattus norvegicus], full insert sequence. [AK007357] |
KLA | .95 |
1.03 |
1.02 |
1.02 |
1.04 |
1.06 |
1.10 |
| ATP | 1.05 |
1.00 |
.95 |
1.10 |
1.00 |
1.03 |
1.02 |
| KLA/ATP | 1.02 |
1.00 |
.89 |
1.09 |
1.09 |
1.06 |
1.06 |
|
Pnlip |  |
NM_026925 |
pancreatic lipase (Pnlip), mRNA [NM_026925] |
KLA | 1.04 |
.97 |
1.04 |
1.00 |
1.02 |
.99 |
.97 |
| ATP | 1.04 |
1.04 |
1.04 |
.96 |
.95 |
1.02 |
.97 |
| KLA/ATP | .99 |
.95 |
.97 |
.99 |
.96 |
.93 |
1.00 |
|
Rbp2 |  |
NM_009034 |
retinol binding protein 2, cellular (Rbp2), mRNA [NM_009034] |
KLA | 1.06 |
1.03 |
1.01 |
1.04 |
1.01 |
1.01 |
1.00 |
| ATP | .99 |
1.02 |
1.01 |
.94 |
.94 |
1.03 |
1.02 |
| KLA/ATP | 1.00 |
1.07 |
1.07 |
1.00 |
.98 |
.98 |
.97 |
|
Scarb1 |  |
NM_016741 |
scavenger receptor class B, member 1 (Scarb1), mRNA [NM_016741] |
KLA | .62 |
.60 |
.60 |
.51 |
.45 |
.40 |
.48 |
| ATP | 1.04 |
1.14 |
.68 |
.89 |
.53 |
.46 |
.82 |
| KLA/ATP | .73 |
.67 |
.40 |
.55 |
.34 |
.30 |
.39 |
|
Slc19a1 |  |
NM_031196 |
solute carrier family 19 (sodium/hydrogen exchanger), member 1 (Slc19a1), mRNA [NM_031196] |
KLA | .94 |
.94 |
.87 |
.82 |
.66 |
.60 |
.78 |
| ATP | 1.03 |
1.16 |
1.08 |
1.23 |
1.13 |
.90 |
.77 |
| KLA/ATP | .95 |
.94 |
.84 |
.97 |
.72 |
.75 |
.62 |
|
Slc19a2 |  |
NM_054087 |
solute carrier family 19 (thiamine transporter), member 2 (Slc19a2), mRNA [NM_054087] |
KLA | 1.04 |
.89 |
.83 |
.53 |
.35 |
.34 |
.42 |
| ATP | .95 |
.77 |
.55 |
.34 |
1.18 |
2.15 |
.36 |
| KLA/ATP | .87 |
.75 |
.66 |
.32 |
.55 |
1.26 |
.38 |
|
Slc19a3 |  |
AK098112 |
cDNA fis, clone TRACH2007674,weakly similar to FOLATE-LIKE TRANSPORTER [AK098112] |
KLA | .95 |
.98 |
1.01 |
.95 |
.96 |
1.03 |
1.02 |
| ATP | 1.00 |
1.00 |
1.10 |
1.06 |
1.01 |
1.03 |
.99 |
| KLA/ATP | 1.01 |
1.03 |
.83 |
1.05 |
1.12 |
.96 |
1.02 |
|
Slc19a3 |  |
NM_030556 |
solute carrier family 19 (sodium/hydrogen exchanger), member 3 (Slc19a3), mRNA [NM_030556] |
KLA | 1.02 |
1.06 |
1.07 |
1.02 |
1.06 |
1.05 |
1.15 |
| ATP | 1.06 |
1.03 |
1.06 |
1.03 |
1.07 |
.98 |
1.07 |
| KLA/ATP | 1.09 |
1.16 |
1.05 |
1.12 |
1.05 |
1.13 |
1.07 |
|
Slc23a1 |  |
NM_011397 |
solute carrier family 23 (nucleobase transporters), member 1 (Slc23a1), mRNA [NM_011397] |
KLA | .94 |
1.00 |
.99 |
1.04 |
1.05 |
.95 |
1.03 |
| ATP | 1.06 |
1.01 |
1.08 |
.94 |
.99 |
.94 |
.96 |
| KLA/ATP | 1.00 |
1.04 |
1.00 |
.96 |
1.04 |
.97 |
.97 |
|
Slc46a1 |  |
NM_026740 |
solute carrier family 46, member 1 (Slc46a1), mRNA [NM_026740] |
KLA | .69 |
.70 |
.68 |
.63 |
.51 |
.55 |
.94 |
| ATP | .94 |
.99 |
1.24 |
1.13 |
.79 |
.49 |
2.42 |
| KLA/ATP | .68 |
.68 |
.78 |
.73 |
.60 |
.49 |
1.32 |
|
Slc5a6 |  |
NM_177870 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 (Slc5a6), mRNA [NM_177870] |
KLA | .46 |
.43 |
.42 |
.47 |
.53 |
.68 |
.99 |
| ATP | .98 |
.94 |
.79 |
.70 |
.66 |
.63 |
1.57 |
| KLA/ATP | .47 |
.42 |
.47 |
.48 |
.51 |
.57 |
1.06 |
|
Tcn2 |  |
NM_015749 |
transcobalamin 2 (Tcn2), mRNA [NM_015749] |
KLA | .93 |
.94 |
1.09 |
.90 |
.91 |
.81 |
.58 |
| ATP | 1.07 |
1.18 |
.91 |
1.28 |
1.03 |
.84 |
.96 |
| KLA/ATP | 1.13 |
1.11 |
.85 |
1.26 |
.86 |
.98 |
.89 |
|